Wise Mind Herbs

 Evidence-based Herbal Healing

The information on this page has been prepared with reference to published scientific literature, not by a medically qualified expert. It is not medical advice. Any decision to use a supplement or herb-based product is your responsibility. Consult a suitably qualified medical professional, especially if you have underlying conditions. Remember, nothing is for everyone, and not everything sold is what it claims to be. Some things work for some people, some of the time.

Hedge Mustard - Sisymbrium officinalis

Hedge mustard (Sisymbrium officinale (L.) Scop.) is a plant in the Brassicaceae family with a long history of traditional medicinal use, particularly for respiratory and vocal conditions. This review examines the current scientific understanding of its health benefits, therapeutic applications, dosing considerations, and potential adverse effects.

A hedge mustard plant

Image source and license: https://commons.wikimedia.org/wiki/File:Hedge_Mustard_-_Sisymbrium_officinale_(detail)_-_geograph.org.uk_-_6496334.jpg.
Modified by Peter Jorgensen.

Botanical Information and Common Names

The primary species with medicinal use is Sisymbrium officinale (L.) Scop., commonly known as hedge mustard, singer's plant, erysimum, or St. Barbara's hedge mustard. Several related species exist within the Sisymbrium genus (around 90 species), including S. irio (London rocket), S. altissimum (tall tumble mustard), and S. loeselii (small tumbleweed mustard). Confusion sometimes occurs between hedge mustard (Sisymbrium officinale) and black mustard (Brassica nigra) or other mustard species, though they contain different phytochemical profiles.

Bioactive Compounds

The therapeutic properties of hedge mustard are attributed to several bioactive compounds including glucosinolates (particularly sinigrin), flavonoids (kaempferol and quercetin derivatives), phenolic acids, essential oils containing sulfur compounds, and mucilages. The seeds contain higher concentrations of glucosinolates than the aerial parts. When plant tissues are damaged, the enzyme myrosinase converts glucosinolates into isothiocyanates, which are believed to be responsible for many of the plant's medicinal effects.

Evidence-Based Health Benefits

Current scientific evidence supports several potential therapeutic applications, though many traditional uses require further clinical validation:

Conditions with Limited or Inconclusive Evidence

Recommended Dosages

Dosage recommendations vary by preparation form and have limited standardization in scientific literature:

Most clinical studies have used preparations standardized to contain 0.5-1% glucosinolates, particularly sinigrin, though standardization practices are not consistent across studies or commercial products.

Safety Profile and Side Effects

Hedge mustard is generally well-tolerated when consumed in recommended dosages. Reported adverse effects include:

High-Dose Studies and Knowledge Gaps

Studies specifically examining doses above the recommended therapeutic range are limited. Animal toxicity studies suggest a reasonably wide therapeutic window, with no significant toxicity observed at doses up to 5 times the standard human equivalent dose. However, comprehensive dose-response studies and long-term safety assessments in humans are lacking. Research gaps include standardized pharmacokinetic studies, dose-optimization clinical trials, and systematic safety evaluations, particularly for extended use beyond 4-6 weeks.

Conclusion

Hedge mustard (Sisymbrium officinale) shows promising therapeutic potential for upper respiratory conditions and vocal health based on traditional use and emerging scientific evidence. However, the quality of clinical evidence remains moderate to low, with many traditional uses lacking robust validation. Future research should focus on standardized preparations, systematic clinical trials, and better characterization of bioactive compounds and their mechanisms of action.

References

Amodeo, V., Marrelli, M., Pontieri, V., Cassano, R., Trombino, S., Conforti, F., & Statti, G. (2019). Chenopodium album L. and Sisymbrium officinale (L.) Scop.: phytochemical content and in vitro antioxidant and anti-inflammatory potential. Plants, 8(11), 505.

Calcinoni, O., Borgonovo, G., Cassanelli, A., Banfi, E., & Bassoli, A. (2021). Herbs for Voice Database: Developing a rational approach to the study of herbal remedies used in voice care. Journal of Voice, 35(5), 807-e33.

Devi, L., Chaudhary, M., Yadav, A., Singh, V. P., Kumar, S., Pal, S., & Suman, A. S. (2023). Medicinal Aspects of Weed: A Review. Int. J. Plant Soil Sci, 35(4), 87-94.

Di Sotto, A., Vitalone, A., & Di Giacomo, S. (2020). Plant-derived nutraceuticals and immune system modulation: An evidence-based overview. Vaccines, 8(3), 468.

Jarrar, H., Alatrash, M., & Amer, F. (2024). Ethnobotanical exploration of botanical remedies used by traditional healers and herbalists for voice disorders. European Journal of Integrative Medicine, 69, 102374.

Khalid, M., Amayreh, M., Sanduka, S., Salah, Z., Al-Rimawi, F., Al-Mazaideh, G. M., ... & Shalayel, M. H. F. (2022). Assessment of antioxidant, antimicrobial, and anticancer activities of Sisymbrium officinale plant extract. Heliyon, 8(9).

Neagu, E., Paun, G., Albu, C., Eremia, S. A. M. V., & Radu, G. L. (2023). Artemisia abrotanum and Symphytum officinale polyphenolic compounds-rich extracts with potential application in diabetes management. Metabolites, 13(3), 354.

Rahman, M., Khatun, A., Liu, L., & Barkla, B. J. (2024). Brassicaceae Mustards: Phytochemical Constituents, Pharmacological Effects, and Mechanisms of Action against Human Disease. International journal of molecular sciences, 25(16), 9039.